ADMINISTRATION OF TICARCILLIN IN EIGHT LEUKEMIC PATIENTS WITH SEVERE GRAM-NEGATIVE INFECTION

DOI Web Site
  • SAWADA HIROYOSHI
    First Divison of Internal Medicine, Faculty of Medicine, Kyoto University
  • TASHIMA MASARO
    First Divison of Internal Medicine, Faculty of Medicine, Kyoto University
  • UCHIDA MICHIHIKO
    First Divison of Internal Medicine, Faculty of Medicine, Kyoto University
  • SASADA MASATAKA
    First Divison of Internal Medicine, Faculty of Medicine, Kyoto University
  • NAKAMURA TORU
    First Divison of Internal Medicine, Faculty of Medicine, Kyoto University
  • UCHINO HARUTO
    First Divison of Internal Medicine, Faculty of Medicine, Kyoto University

Bibliographic Information

Other Title
  • 白血病患者の感染症に対するTicarcillinの使用経験
  • ハッケツビョウ カンジャ ノ カンセンショウ ニ タイスル Ticarcill

Search this article

Abstract

Ticarcillin was applied to eight leukemic patients with severe gram-negative infections. Six of 8 cases could be evaluated on the effect of ticarcillin in this trial. Five of 6 cases with Pseudomonas pneumonia or with pneumonia caused by Pseudomonas and other gram-negative organisms were cured or improved. One case with Pseudomonas pneumonia was failed to respond. No remarkable side effect was observed except one erythematous skin rash, and one phlebitis patient. It is expected that ticarcillin may constitute an advance in the antibiotic treatment against Pseudomonas infection in patients of leukemia.

Journal

  • CHEMOTHERAPY

    CHEMOTHERAPY 25 (9), 2609-2613, 1977

    Japanese Society of Chemotherapy

Details 詳細情報について

Report a problem

Back to top